HK2 and plasma cell myeloma: The expression of NEK2 and glycolysis-enhancing genes, such as hexokinase 2 (HK2), alpha-enolase (ENO1), and lactate dehydrogenase A (LDHA), was significantly increased in high-risk myeloma samples and positively correlated each other (Fig. 3a).